文献速递妇产影像泌尿生殖MR

基于血氧水平依赖磁共振成像的R2*值对新辅助化疗后宫颈鳞状细胞癌淋巴结转移的预测价值

Predictive value of R2∗ values derived from blood oxygen level-dependent magnetic resonance imaging for lymph node metastasis after neoadjuvant chemotherapy for cervical squamous cell carcinoma.
PubMed 文献 · Clin Radiol · 2025-10-30

该前瞻性研究纳入67例IB-IIA期宫颈鳞状细胞癌患者,在新辅助化疗前及术前1周内行常规MRI和BOLD-MRI。结果显示淋巴结转移组化疗后R2*值低于无淋巴结转移组(P<0.001),提示化疗后原发肿瘤R2*值可能作为预测新辅助化疗后淋巴结转移的影像生物标志物。

要点

  • 淋巴结转移组化疗后R2*值低于无淋巴结转移组(P<0.001)。
  • 两组化疗后R2*值均高于化疗前(P=0.017和P<0.001)。
  • 淋巴结转移组化疗后TS值较化疗前降低(P<0.001)。

核心结论

  • 新辅助化疗后原发肿瘤的R2*值可能作为预测宫颈鳞状细胞癌患者新辅助化疗后淋巴结转移的有价值影像生物标志物。

研究设计与样本

  • 前瞻性研究,纳入67例诊断为宫颈鳞状细胞癌并计划在新辅助化疗后行根治性子宫切除术的患者。
  • 每例患者在新辅助化疗前1周内及术前1周内分别行常规MRI和BOLD-MRI检查。
  • 以术后病理淋巴结转移状态为参考,15例归为淋巴结转移阳性,52例归为淋巴结转移阴性。

关键影像表现/征象

  • 淋巴结转移组化疗后R2*值低于无淋巴结转移组(P<0.001)。
  • 两组化疗后R2*值均高于化疗前(淋巴结转移组P=0.017,无淋巴结转移组P<0.001)。
  • 两组化疗后TS值均低于化疗前(P<0.001)。

诊断标准与关键数值

  • 术前1周内基于实体瘤疗效评价标准1.1版评估,无患者出现疾病进展。
  • 淋巴结转移组与无淋巴结转移组在FIGO分期、淋巴血管间隙浸润状态、间质浸润深度及新辅助化疗反应方面差异有统计学意义(P<0.05)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: The aim of this study was to investigate the predictive value of R2∗ values obtained from blood oxygen-level-dependent magnetic resonance imaging (BOLD-MRI) for lymph node metastasis (LNM) after neoadjuvant chemotherapy (NACT) in patients with stage IB-IIA cervical squamous cell carcinoma (CSCC).

MATERIALS AND METHODS: Patients diagnosed with CSCC and scheduled to undergo radical hysterectomy following NACT were prospectively recruited. Each patient underwent conventional MRI and BOLD-MRI within 1 week before NACT and again within 1 week before surgery.

RESULTS: In this study, 67 patients diagnosed with CSCC were recruited. Of the 67 evaluable women, 15 were finally classified as LNM-positive and 52 as LNM-negative. The evaluation based on the Response Evaluation Criteria in Solid Tumours version 1.1 performed within 1 week before surgery showed that none of the patients had progressive disease. No significant differences were observed between the LNM and non-LNM groups in basic clinical information (P > 0.05). Statistical differences were found between the patients who ultimately developed LNM (LNM group) and those who did not (non-LNM group), as well as in Federation of Gynaecology and Obstetrics staging, lymphovascular space invasion (LVSI) status, depth of stromal invasion, and NACT response (P < 0.05). In both groups, R2∗post-NACT values were higher than R2∗pre-NACT (P = 0.017 and P < 0.001), whereas TSpost-NACT values were lower than TSpre-NACT values (P < 0.001). The LNM group had lower R2∗post-NACT values than the non-LNM group (P < 0.001).

CONCLUSION: The R2∗post-NACT value of the primary tumour derived from BOLD-MRI may serve as a valuable imaging biomarker for predicting post-NACT LNM in CSCC patients.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Yin L, Zhang J, Pang Y, et al. Predictive value of R2∗ values derived from blood oxygen level-dependent magnetic resonance imaging for lymph node metastasis after neoadjuvant chemotherapy for cervical squamous cell carcinoma. Clin Radiol. 2025. PMID: 41577492. doi:10.1016/j.crad.2025.107149

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。